Fear Sells: Studies on Mutant H5N1 Virus Finally Published

AFP | MAY 3, 2012

Scientists who created a mutant virus to explore a key aspect of influenza published their research Wednesday after a four-month storm that brewed fears of bioterrorism and accusations of censorship.

The controversy began in December when teams in the United States and the Netherlands separately said they had engineered a hybrid virus in high-security labs.

Their goal was to understand how a highly lethal strain of flu which spreads among birds but is hard to transmit to mammals could mutate into a variant that is contagious among humans.

A 23-member expert panel that advises the US government called for manuscript changes before the work could be published in a journal, the traditional arena for displaying and discussing scientific work.

It feared that full disclosure could help a rogue state or bioterror group make a virus against which no-one would be immune.

But some scientists lashed the recommendation, saying it was an attempt to censor or stifle scientific discourse.

Two journals put the papers on hold while they consulted the researchers and the panel, the National Science Advisory Board for Biosecurity (NSABB).

On Wednesday, the British journal Nature finally published one of the studies, conducted by a team led by Yoshihiro Kawaoka at the University of Wisconsin.

“The essential scientific elements (in the original manuscript) were unchanged,” the journal said, adding it was publishing the paper after receiving “several independent pieces of biosecurity advice”.

Kawaoka’s team delved into the H5N1 strain of avian flu, which caused a health scare in Hong Kong in 1997 and still surfaces sporadically today.

H5N1 spreads easily among poultry and wild birds but is hard to transmit to humans. When it does, it is brutal, killing more than one infected person in two.

The team took a key gene, known as haemagluttinin or HA, from the H5N1 virus and added a mutation that made it more compatible with human respiratory cells.

They then took a strain of H1N1 flu — the virus that caused a pandemic among humans in 2009 but proved to be no more lethal than ordinary seasonal flu — and replaced its HA gene with the engineered one.

The next step was to test the “H5/H1 hybrid” on six ferrets, a mammal deemed an excellent model for testing flu because its respiratory system is so similar to that of humans.

The infected ferrets passed on the virus to others in respiratory droplets, thus proving that the new virus could be spread through coughs and sneezes.

But none of the animals died, something that remains to be explained, said the researchers.

The findings shed light on the genetic borrowings that help a virus gain in contagiousness, they said. This risk is all too present in nature, especially in pigs, which can mix avian, human and porcine viruses.

The work will help alert health watchdogs to emerging viral threats and provide vaccine engineers with potential targets, they argued.

Nature showed journalists a report from “a bio-defence agency outside the US”, which it declined to name, that said the benefits of publication outweighed the risks.

“This information could be used by an aggressor and shows one of the building blocks for the development of a potential BW [biowarfare] weapon,” the report said.

“[Such skill] is a demanding capability, probably beyond the capacity of the majority of those groupings of concern,” it said.

“On the other hand, not publishing this information would slow, or even block, the development of a vaccine against a virus that still has the potential to mutate naturally to a pandemic form, which could cause huge numbers of fatalities worldwide.”

Touching on the tension between freedom of expression and scientific responsibility, Nature said it was “desirable” to have a forum such as NSABB but in this case the panel had over-reacted.

“There are justified concerns among the research community about the NSABB’s processes, and these processes should be reviewed.”

The other paper, intended for the US journal Science, is written by Ron Fouchier of the Erasmus Medical Centre in Rotterdam.

The American Association for the Advancement of Science (AAAS), which publishes the journal, said Fouchier’s study was undergoing peer review — the traditional scrutiny in scientific publications.

“We had originally hoped, as a public service, to be able to publish Dr. Fouchier’s paper simultaneously with the similar research by Dr. Kawaoka. But appropriate review and editing of the manuscript is the primary goal,” said AAAS spokeswoman Ginger Pinholster.

H5N1 GMO Virus a plot to sell Tamiflu?

Scientists contradict themselves as they stated the super virus had been created in lab experiment.

By DAVID BROWN | WASHINGTON POST | APRIL 4, 2012

Two controversial research projects with the H5N1 bird flu virus haven’t produced a killer bug but have generated useful information, two researchers told scientists and bioethicists gathered here to talk about the benefits and pitfalls of manipulating deadly pathogens.

“We can use this information to understand what’s happening in nature,” Yoshihiro Kawaoka of the University of Wisconsin told the group, which is meeting to discuss experiments on the much-feared flu strain that has infected 600 people, killing more than half of them, since 2003. He said his work is already shedding light on outbreaks in Egypt, the country with the second-largest number of H5N1 cases over that period.

The meeting at the Royal Society was called after two science journals agreed in December to hold off publishing two papers on the bird flu experiments because they were thought to contain information too dangerous for public consumption. The journals were asked to do so by the National Science Advisory Board for Biosecurity, a committee of scientists that advises the U.S. government about federally funded research, such as these experiments.

That committee changed its mind last week after a closer examination of old and new data provided by Kawaoka and Ron Fouchier, who heads a research team at Erasmus Medical Center in Rotterdam. The journals, Nature and Science, say they plan to publish the papers soon.

A few details of Fouchier’s experiment were released last month, allaying some fears about its hazards. Kawaoka revealed an even fuller version of his work here Tuesday, further defusing worries. Numerous listeners, however, said it is only a matter of time before the question of whether to publish the results of “dual-use research” — research that could be used for good or bad purposes — comes up again.

Normally, bird flu is hard for people to catch. It requires close contact with sick birds and almost never passes from person to person. The ease of transmission is mostly determined by the structure of one protein, hemagglutinin. Kawaoka wanted to find out what mutations in that protein’s gene might make the virus more contagious in people.

He put a bird flu hemagglutinin gene into the 2009 pandemic “swine flu” virus and by various methods induced four mutations in it. The final bug was easily passed between ferrets, unlike viruses containing a “wild” bird flu hemagglutinin gene. But the engineered virus didn’t kill the animals and didn’t even make them as sick as the swine flu virus. The infections were also easily stopped with the drug Tamiflu.

Read Full Article →

Daftar Akun Bandar Togel Resmi dengan Hadiah 4D 10 Juta Tahun 2024

Togel resmi adalah langkah penting bagi para penggemar togel yang ingin menikmati permainan dengan aman dan terpercaya. Tahun 2024 menawarkan berbagai kesempatan menarik, termasuk hadiah 4D sebesar 10 juta rupiah yang bisa Anda menangkan. Anda perlu mendaftar akun di Daftar Togel yang menawarkan hadiah tersebut. Proses pendaftaran biasanya sederhana dan melibatkan pengisian formulir dengan informasi pribadi Anda serta verifikasi data untuk memastikan keamanan transaksi. Setelah akun Anda selasai terdaftar, Anda dapat berpartisipasi dalam berbagai permainan togel berbagai fitur yang disediakan oleh situs togel terbesar.

Bermain di Link Togel memungkinkan Anda memasang taruhan dengan minimal 100 perak, sehingga semua kalangan bisa ikut serta. Meskipun taruhan rendah, Anda tetap bisa memenangkan hadiah besar dan mendapatkan bonus. Untuk mulai bermain, Anda harus mendaftar terlebih dahulu.

Bagi pemain togel yang ingin menikmati diskon terbesar, mendaftar di situs togel online terpercaya adalah langkah yang tepat. Bo Togel Hadiah 2d 200rb tidak hanya memberikan jaminan keamanan dalam bertransaksi, tetapi juga menawarkan berbagai diskon untuk jenis taruhan tertentu. Diskon yang besar ini memungkinkan pemain untuk menghemat lebih banyak dan memasang taruhan dalam jumlah yang lebih banyak. Dengan begitu, peluang untuk mendapatkan hadiah juga semakin tinggi, sekaligus memastikan bahwa setiap taruhan dilakukan di situs yang aman dan resmi.

Link Slot Gacor Terpercaya untuk Menang Setiap Hari

Slot gacor hari ini menjadi incaran para pemain Link Slot Gacor yang ingin menikmati peluang jackpot besar hanya dengan menggunakan modal kecil, sehingga mereka bisa merasakan pengalaman bermain yang lebih menyenangkan dan penuh keuntungan.

Related Links:

Togel178

Pedetogel

Sabatoto

Togel279

Togel158

Colok178

Novaslot88

Lain-Lain

Partner Links